发明名称 Derivado de 7-piperidinalquil-3,4-dihidroquinolona
摘要 PROBLEM To provide a novel compound, a pharmaceutically acceptable salt or a hydrate thereof useful for preventing or treating for depression, anxiety disorders (such as generalized anxiety disorder, posttraumatic stress disorder, panic disorder, obsessive-compulsive disorder or social anxiety disorder), attention deficit disorder, mania, manic-depressive illness, schizophrenia, mood disorders, stress, sleep disorders, attacks, memory impairment, cognitive impairment, dementia, amnesia, delirium, obesity, eating disorder, appetite disorder, hyperphagia, bulimia, cibophobia, diabetes, cardiovascular diseases, hypertension, dyslipidemia, myocardial infarction, movement disorder (such as Parkinson's disease, epilepsy, convulsion or tremor), drug abuse, drug addiction or sexual dysfunction, based on a melanin-concentrating hormone receptor (MCH receptor) antagonistic action. SOLUTION A compound, a pharmaceutically acceptable salt or a hydrate thereof represented by the formula (I).
申请公布号 ES2424393(T3) 申请公布日期 2013.10.01
申请号 ES20090817928T 申请日期 2009.09.30
申请人 TAISHO PHARMACEUTICAL CO., LTD. 发明人 KANUMA, KOSUKE;MIYAKOSHI, NAOKI;KAWAMURA, MADOKA;SHIBATA, TSUYOSHI
分类号 C07D401/06;A61K31/4709;A61P1/14;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P15/10;A61P25/00;A61P25/02;A61P25/08;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/36;A61P43/00;C07D401/14 主分类号 C07D401/06
代理机构 代理人
主权项
地址